. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Am J Reprod Immunol. 2014 Oct 23;73(3):273–284. doi: 10.1111/aji.12332

Table 2.

Association of HIV infection and HIVRNA levels with AMH levels

Model	HIV-infected		Uninfected Controls (N = 941)
Model	Undetectable HIVRNA (N = 698^*)	Detectable HIVRNA (N =1946)	Uninfected Controls (N = 941)
Unadjusted AMH level^**	0.56 (0.48, 0.65)	0.37 (0.33, 0.42)	0.63 (0.53, 0.74)
	% Estimate (95%CI)^‡	% Estimate (95%CI)^‡
Adjusted for age	−15.7 (−25.3, −4.8), p=0.0058	−25.6 (−33.5, −16.8), p<.0001	Reference
Multivariable-adjusted^§	27.7 (10.4, 47.9), p=0.0010	31.2 (13.5, 51.6), p=0.0002	Reference

sample size given at baseline. The numbers within each group may change during follow-up as a result of increases or decreases in HIVRNA levels, as well as seroconversion among participants who were uninfected at baseline.

^**

estimated geometric mean AMH level (ng/mL) at age 40, with 95%CI.

^‡

AMH is log-transformed; results are back-transformed to produce estimated percentage differences in AMH attributable to each factor. Estimates are from mixed models for left-censored repeated measures.

^§

Adjusted for age, race, current smoking, current hormonal contraceptive use, history of amenorrhea, history of weight loss, current CD4 count, nadir CD4 count, nadir CD8 count, and nadir T lymphocyte count.